A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications that may be associated with longer survival in people with amyotrophic lateral sclerosis (ALS). The research is published in The Lancet Digital Health journal.
This article was originally published on MedicalXpress.com

